Previous 10 | Next 10 |
home / stock / seovf / seovf news
(TheNewswire) LONDON, ONTARIO - TheNewswire – December 16, 2021 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH), a clinical-stage regenerative medicine and cell therapy therapeutics company focused on developing a potential ‘functional cure&...
(TheNewswire) LONDON, ONTARIO - TheNewswire - December 14, 2021 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH), a clinical-stage leader in regenerative medicine and cell therapy therapeutics developing a potential ‘functional cure’ for type...
(TheNewswire) LONDON, ON - TheNewswire - December 2 , 2021 - Sernova Corp . (TSXV:SVA) (FSE/XETRA:PSH)(OTC:SEOVF), a leading clinical-stage company focused on regenerative medicine therapeutics, is pleased to announce that ...
(TheNewswire) LONDON, ON - TheNewswire – November 16 , 2021 -- Sernova Corp . (TSXV:SVA)(FSE/XETRA:PSH)(OTC:SEOVF), a leading clinical-stage company focused on regenerative medicine therapeutics, today announced that Dr. P...
(TheNewswire) Information Session Webinar on Sernova’s Conformal Coating Immune Protection Technology with Dr. Toleikis and International Expert, Dr. Tomei Now Available on Sernova’s Website L ondon, Ontario - TheNewswire - October 1, 2021 - Serno...
(TheNewswire) Integrated Advisory and Investor Relations Program to Focus on Elevating Company’s Visibility in US Capital Markets Ahead of Projected Corporate Milestones LONDON, ONTARIO - TheNewswire - September 29, 2021 - Sernova Corp. (TSXV:SVA) (OTC:S...
(TheNewswire) Collaboration to build on positive Cell Pouch T1D Clinical Outcomes and preclinical success in Global Pharmaceutical Collaborations to develop regenerative medicine therapeutic cures without life-long immunosuppression medications across multiple diseases ...
(TheNewswire) L ondon , ON - TheNewswire - August 9 , 2021 - Sernova Corp . (TSXV:SVA) (FSE/XETRA:PSH) (OTC:SEOVF), a leading clinical-stage company focused on regenerative medicine therapeutics, today announced t...
Click here to read the previous top Canadian pharma stocks article. The Canadian pharmaceutical industry has positioned itself firmly on the global map thanks to advances in biotechnology and investments in medical research and development. The life science s...
(TheNewswire) LONDON, ONTARIO - TheNewswire - July 5, 2021 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH) , a leading clinical-stage regenerative medicine therapeutics company, held its annual shareholder meeting (the “Meeting”) via the virtua...
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – TheNewswire - July 15, 2024 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatment o...
(TheNewswire) To date Sernova reports 7 patients in its Phase I/II type 1 diabetes clinical trial achieved freedom from insulin injections and demonstrate blood sugar control in the non- diabetic range (HbA1c 6.5%); 6 patients have reached between 5.5 and 50 months o...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – June 12, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatmen...